Lansoprazol er (ligesom misoprostol) effektivt til at reducere risikoen for gastriske og duodenale ulcera hos patienter, der kræver fortsat NSAID- behandling.
Lansoprazole (like misoprostol) is effective in reducing the risk of gastric or duodenal ulcers in patients who need to continue NSAIDs.